Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why TransMedics Group Stock Is Soaring Today


Shares of TransMedics Group (NASDAQ: TMDX) were soaring 11.1% higher as of 11:22 a.m. ET on Thursday. The big gain came after the medical technology company announced its second-quarter results following the market close on Wednesday.

TransMedics reported Q2 revenue of $114.3 million, up 118% year over year. It generated net income of $12.2 million, or $0.35 per diluted share. In the same quarter of 2023, TransMedics posted a net loss of $1 million.

The company also raised its full-year revenue guidance to between $425 million and $445 million, which reflects year-over-year growth of 76% to 84%. TransMedics previously projected full-year revenue in the range of $390 million to $400 million.

Continue reading


Source Fool.com

Like: 0
Share

Comments